We studied the feasibility and the sensitivity of fluorescent in situ hybridization (FISH) using leukemic or host/donor-specific probes on flow-sorted cells to assess minimal residual disease (MRD) or chimerism in transplanted patients in complete remission. We first performed experimental models of
β¦ LIBER β¦
Real-time PCR for monitoring minimal residual disease and chimerism in patients after allogeneic transplantation
β Scribed by Ahmet H. Elmaagacli
- Publisher
- Carden Jennings Publishing
- Year
- 2002
- Tongue
- English
- Weight
- 511 KB
- Volume
- 76
- Category
- Article
- ISSN
- 0925-5710
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Fluorescent in situ hybridization on flo
β
S. Cotteret; F. Belloc; J. M. Boiron; C. Bilhou-Nabera; P. Dumain; C. Boyer; F.
π
Article
π
1998
π
John Wiley and Sons
π
English
β 231 KB
Minimal residual disease monitoring afte
β
MarΓa DΓez-Campelo; JosΓ© Antonio PΓ©rez-SimΓ³n; Jose PΓ©rez; Miguel Alcoceba; Juan
π
Article
π
2009
π
John Wiley and Sons
π
English
β 93 KB
Quantitation of minimal residual disease
β
Sugimoto, Takeshi; Das, Hiranmoy; Imoto, Shion; Murayama, Tohru; Gomyo, Hiroshi;
π
Article
π
2000
π
John Wiley and Sons
π
English
β 104 KB
π 2 views
t(8;21) is one of the common chromosomal translocations in acute myelogenous leukemia (AML). Using a recently developed real-time quantitative polymerase chain reaction (PCR) system, we analyzed the minimal residual disease (MRD) in bone marrow samples from seven AML patients with t(8;21) at differe
The value of monitoring minimal residual
β
Xiao Ma; Depei Wu; Aining Sun; Huiying Qiu; Zhenzhen Fu; Xiaojin Wu; Suning Chen
π
Article
π
2009
π
John Wiley and Sons
π
English
β 389 KB
π 2 views
8. Monitoring of minimal residual diseas
β
D. ΕadoΕ; J. JΓ³Εkowska; A. Wojda; A. Pieczonka; D. Boruczkowski; M. Leda; J. Wac
π
Article
π
2001
π
Wielkopolskie Centrum Onkologii
π
Polish
β 162 KB